Novo Holdings, Catalent Reset Review Clock On $16.5B Deal

By Matthew Perlman · April 4, 2024, 6:10 PM EDT

Novo Nordisk Foundation has given the Federal Trade Commission more time for an initial review of Novo Holdings' plan to acquire Catalent in a deal that values the pharmaceutical services company...

To view the full article, register now.